List of Vendor Companies in New York - 148

Aanika Biosciences, Inc. provides food security services for large food and agricultural companies. We use synthetic biology to ensure the integrity of supply chains and reduce potential losses.

Calspan is an industry-leading research and testing partner to the great innovators of the aerospace and automotive industry. We assist both industries in overcoming developmental and technical challenges to ensure their creative concepts become viable commercial products. Calspan's business units work with integrity, collaboration, and years of experience to accelerate the world's greatest innovations on land or into the sky. Our operations span across the United States. Calspan's corporate headquarters are in Buffalo, NY and the headquarters for Calspan Flight are in Niagara Falls, NY. Additional test pilot training is conducted at Patuxent River, MD and Edwards Air Force Base, CA. Our main automotive testing campus is in Buffalo, NY with breakout locations in NY, PA, NJ, MD, MI, FL, NC and TN. Calspan Test Solutions provides aerodynamic testing, including hypersonics, and aerodynamic model solutions is in St. Paul, MN. Lastly, Calspan Test Systems provides R&D, T&E engineering and manufacturing solutions with locations in Newport News, VA, Hampton, VA, San Diego, CA, and Ronkonkoma, NY.

Aclid is a security and safety platform for synthetic biology. The company's DNA screening solution for biosecurity, export control compliance, and EH&S keeps researchers safe and protects national security.

Actylis is a chemicals company that specializes in acetates and provides pharmaceuticals, fine chemicals, and industrial chemicals.

Founded in 1998 and based in Plainview, NY (Long Island), Acupath is a nationwide provider of sub-specialized anatomic pathology services focused on the following specialties; Urology, Gastroenterology, Hematology / Oncology, Dermatology, Breast, Gynecology, Otolaryngology, Podiatry, and Oral. Acupath offers an extensive test menu on both a global and TC/PC basis, has well over 500 active clients, processes well over 150,000 specimens annually, and is one of the leading providers of cutting edge FISH testing for the detection of bladder cancer (UroVysion™), prostate cancer (PTEN ERG), and esophageal cancer (Barrett's esophagus FISH).

Advanced Resilient Biocarbon is a company that specializes in biocarbon production through licensed pyrolysis systems.

Advion is a manufacturer and supplier of mass spectrometers and analytics systems for life science and pharmaceutical sectors.

Affina Biotechnologies is dedicated to excellence in helping our customers develop measurements of activities, kinetics and affinities of interactions and concentrations of biomolecules. We offer a unique mix of label-free and label-dependent assay technologies supported by scientific and technical expertise and a wide range of instrumentation: Surface Plasmon Resonance (SPR) Light absorbance, luminescence, fluorescence polarization, time-resolved fluorescence Affina scientists will work with you on developing custom-built measurements and screens that are tailored to your requirements. Once a method is developed and validated we will help you transfer it to your facility of choice or perform it at Affina. The services listed are the major ones that we provide. If there is a type of measurement that can use our technologies and is not listed here we will be happy to work on it with you! Affinity and kinetics of molecular interactions Enzyme activity Total and active concentration

The Genomics Core serves the Einstein scientific community by providing a broad range of services, utilizing current and emerging nucleic acid technologies. Single-cell assays, MPS, Microarrays, real-time PCR, Sanger sequencing and assay automation are available. The Core provides a number of technologies for genotyping DNA from humans or model organisms, varying from SNP (single nucleotide polymorphism) typing to targeted sequencing for variant discovery.

Nature's solution for food's future. Engineering sustainable food solutions for all. As a food-tech company, Algama harvests the potential of algae to create food that's good for both people and the planet. Algama's goal is to feed 10 billion people by 2050, while preserving the planet and offering consumers additional and better choices in foods. Our story After consuming microalgae for numerous reasons, Alvyn and Gaëtan conclude that it was a viable solution with the potential to redefine our food system for good. Algama was founded in 2013. World leader in algae food Since its founding, Algama has been the world leader in microalgae food and is proud to have the support of world-class impact investors like Horizons Ventures, Blue Horizon Ventures, CPT Capital, Veginvest, Beyond Impact, Alwyn Capital. All the team is dedicated to innovate and make microalgae a key resources for tomorrow's daily food. Algama team We are focused on bringing microalgae-based foods to market, we are working hard to make our ingredients and products super tasty, affordable and widely available. We are expecting the team and we are looking for talents, innovateurs and entrepreneurs.

Amerigo is a distribution company providing essential supplies and services to the biomedical and life science research communities. Amerigo's founder has had more than 20 years of rich experience in the biomedical and biochemical fields and has established close contacts with key personnel in top international pharmaceutical and biotech companies, academic research institutes, and government research agencies. Amerigo's most valuable asset is a professional team, skilled at giving effective technical and customer support. Most of our employees own a graduate (Ph.D. or master) degree in life science, ready to understand customers' questions or concerns and provide individualized customer service with high standards. Our mission is to integrate premium product resources worldwide, simplify the search process for scientists, and provide the scientific community with the latest, professional solutions.

Anellotech’s patentedBio-TCat™process produces 100% bio-based BTX (i.e. benzene, toluene and xylene) ‘drop-in’ aromatic chemicals, offering a solution to the lack of efficient, scalable processes for producing BTX fromrenewable, non-food biomass.In addition to BTX, Bio-TCat technology produces a heavier aromatics product, which can be used as bio-marine fuel, or can be upgraded to make diesel or jet fuel blendstocks.

Apath is a privately held technology licensing company founded by Dr. Charles M. Rice, Nobel Laureate in Medicine 2020, engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies in discovering and developing therapeutic products for the treatment of viral infections. Apath is the premier technology licensing company of research and development tools utilized to validate therapies for the hepatitis C virus, respiratory syncytial virus, Ebola virus, sindbus virus, West Nile virus, and permissive cell line technologies utilized in research surrounding influenza and SARS-CoV-2. We represent multiple academic institutions and commercial entities holding the fundamental intellectual property required for developing HCV and RSV Therapeutics, Antibodies, Vaccines, and SARS-CoV-2-related therapeutics.

AptaMatrix is a privately held, start-up biotechnology company headquartered in Syracuse, New York. The company's focus is to accelerate the rate of aptamer discovery using its patent pending High Throughput Screening of Aptamers (HTSA) approach in addition to developing its novel AlloSwitch™ sensor technology capable of a) creating rapid diagnostic tools for detection of chemical and biological targets, and b) leveraging this diagnostic platform for drug discovery applications. AlloSwitches™, have demonstrated the ability to transduce molecular recognition of biological targets into a real-time (seconds) optical signal for identifying environmental and terrorist released contaminants in liquid systems. HTSA and AlloSwitch solutions are built on patented biotechnology based on years of leading-edge biological research and industry partnerships at Syracuse University. The HTSA approach leverages the high throughput capabilities of deep-sequencing technology. All sequencing activity is managed by our Genomics Division and conducted on our Illumina GAIIx platforms. Data analysis is supported by our in-house bioinformatics team. In addition to supporting internal research and development, our genomics division actively supports both academic and commercial deep-sequencing projects.

Aquavit Pharmaceuticals, Inc. is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, medical devices and health technologies. We focus on personalized medicine to improve patient health and to maximize the efficiency of the medical community. At Aquavit Pharmaceuticals, Inc., we combine this strategic focus with a modern, diverse approach that enables us to pursue new specialty areas with significant unmet needs. Science personalized. Healthcare modernized.

Argon AI is a platform that allows biopharmacy and life sciences experts to conduct complicated, data-driven operations. They help life sciences companies automate their data-intensive workflows with unprecedented AI.

When it comes to solving our world's biggest problems, the answers can often be found in nature. The forest is a great place to begin. A lot goes on—between the dirt and the squirrels, and the mosses and the trees—but, what interests us most is what's happening just beneath the forest floor, where lies a hidden, entangled root system of fungi called mycelium. We've studied and become inspired by mycelium. We've learned there's a lot you can do with it—from textiles to building materials to packaging alternatives, even to food! Really tasty food. Guided by the wisdom of the woods, MyForest Foods is harvesting this new approach to meatless food—one that can sustain AND satisfy all types of eaters. Our mycelium is grown—not ground, so it actually feels like you're biting into a whole cut of meat. Our flagship product, MyBacon is the first of many plant-based, clean-label, mycelium-grown eats we have planned. Mycelium—MyBacon's star ingredient—is a complete protein with a naturally high nutritional profile, and it's what gives MyBacon its amazing texture. Our chefs brine each strip using a special recipe with minimal ingredients: flaked salt, cane sugar, natural flavors and beet juice for color. Add a little coconut oil for the perfect sizzle, and you're looking at a seriously meat-like bacon alternative, so reminiscent of the traditional bacon-y flavors and textures you love. Now that we've figured out how to create a sustainable supply of eats, it's our aim to pass the plate around the planet, honoring mycelium's potential to feed the future, one delicious bite at a time.

Basepair is a next generation bioinformatics company. Through a combination of intuitive interfaces and modern architecture we are reimagining what a commercial platform can deliver to R&D organizations. We're on a mission to make genomic data analysis & visualization more accessible to a broader range of scientists so that the promise of precision medicine can become a reality. One of the biggest challenges preventing this now arguably lies not with how the data gets generated and processed, but who is able to perform the analysis and understand what the resulting data means. Limiting this work to a select few, whether through choice or more often because of technology restrictions, especially for routine analyses, leads to reduced efficiency in R&D teams, longer times to market for assay manufacturers and increased turnaround times in clinical settings. Unlike other more traditional alternatives, our philosophy is not to ask bioinformaticians to change the way they work by having to build workflows on our platform. Instead, once they are built and ready for sharing or production settings, Basepair can significantly improve and accelerate both scaling & deployment to colleagues, collaborators and customers wherever they happen to be in the world. To do this in a way that is adapted to the dynamics of the market today, we believe a bioinformatics platform needs to: 1) Leverage the compute and storage resources in a third party cloud account without the requirement of installing inside an organization's vpc 2) Facilitate the bundling of analysis with the sale of a kit or assay through easy white labeling and tokens/coupons 3) Support ever increasing sample volumes and application areas through an extensible architecture that scales to millions of records, enables complete sample provenance and reduces cloud costs Introducing Basepair…bioinformatics reinvented.

Biolumina is a full-service, integrated agency delivering customized, data-driven solutions for oncology brands.

For over 30 years, Bionique Testing Laboratories has been a trusted partner and global leader of Mycoplasma Testing Services for the life science industry. Bionique offers the full breadth of GMP services from Lot & Final Drug Product Release Testing to Real-Time PCR assays. Our service portfolio and depth of expertise enables us to support our clients’ needs from concept through clinical trials to commercialization for biopharmaceutical and cell therapy products. Our capabilities extend to successful method development and validation inclusive of rapid microbiological methods to generate real time results. Bionique stands ready to provide the highest quality of mycoplasma testing services to ensure the integrity and biosafety of your therapeutic products. Mycoplasma Testing Solutions for: • Cell and Gene Therapy Products • Clinical Trial Materials • Biopharmaceuticals • Master and Working Cell Banks • Raw Materials • Vaccines Bionique is a cGMP compliant, FDA-registered facility.

For over 30 years, Bionique Testing Laboratories has been a trusted partner and global leader of Mycoplasma Testing Services for the life science industry. Bionique offers the full breadth of GMP services from Lot & Final Drug Product Release Testing to Real-Time PCR assays. Our service portfolio and depth of expertise enables us to support our clients' needs from concept through clinical trials to commercialization for biopharmaceutical and cell therapy products. Our capabilities extend to successful method development and validation inclusive of rapid microbiological methods to generate real time results. Bionique stands ready to provide the highest quality of mycoplasma testing services to ensure the integrity and biosafety of your therapeutic products. Mycoplasma Testing Solutions for: • Cell and Gene Therapy Products • Clinical Trial Materials • Biopharmaceuticals • Master and Working Cell Banks • Raw Materials • Vaccines Bionique is a cGMP compliant, FDA-registered facility.

Our unique modular closure system is called the Xvivo System model X2. Many people dismiss it as simply another isolator. It does look like one and has glove access where necessary in the workflow. However, unlike isolators it has extensive plug-and-play modularity so it can enclose any production process. Less obvious but just as important, it can easily be reconfigured to quickly accommodate any changes or improvements to the process such as new equipment or automation, or as you need to scale

BlinkRx is the world's first pharma-to-patient cloud that offers a digital concierge service for patients who are prescribed branded medications. Patients benefit from transparent low prices, free home delivery, and world-class support on this first-of-its-kind centralized platform. With BlinkRx, never again will a patient show up at the pharmacy only to discover that they can't afford their medication, their doctor needs to fill out a form for them, or the pharmacy doesn't have the medication in stock. We are a highly collaborative team of builders and operators who invent new ways of working in an industry that historically has resisted innovation. Join us!

BOC Sciences provides a wide variety of custom services which range from bulk compounds to specialty species in the pharmaceutical, agrochemical, and biotechnology industries. We are committed to providing our customers with the best products and services at the most competitive prices. Given diverse packing options for most of our chemicals, you are welcome to order the desired compounds in any quantities from a few mg to several kg along with all the relevant technical reports. We sincerely hope that our unremitting pursuits of excellence, success, and professionalism will add immense value to your research and development projects!

Buffalo Brewing Company is a craft brewery that specializes in small batch hand crafted beers, offering an intimate tasting room and large beer garden.

Byrne Dairy is a fourth generation, family-owned producer and distributor of Greek Yoghurt, Conventional Yogurt, Sour Cream, Milk, Cream, Ice Cream and a variety of other dairy products. Byrne Dairy currently has four manufacturing facilities including a Fresh Dairy Plant and Ice Cream Plant located in Syracuse, NY and a Cultured Plant located in Cortlandville, NY.

C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil. Palm oil is everywhere: it’s in our food, clothes, shampoo, and even the fuel that powers our cars. But this $61 billion industry has drastic environmental and societal costs: rainforests from Costa Rica to Indonesia are destroyed to make way for oil palm tree plantations, releasing carbon dioxide into the atmosphere and destroying habitats for people and endangered wildlife along the way. But palm oil doesn't have to be a problem. There remains an urgent need for consumers and companies alike to switch to environmentally conscious, sustainable palm oil products. C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to conflict palm oil. By offering producers, refiners, traders and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability efforts, our aim is to reduce the environmental footprint of palm oil production and protect precious natural land, wildlife, and resources in the process. We've developed technology to brew a sustainable alternative to palm oil from microbes. Fermentation is a well-proven commercial process that has been used for centuries to convert raw materials into consumable commercial products consumed by billions of people every day. We believe that brewing palm oil like beer is the best and most likely path to developing a truly sustainable palm oil alternative. Our palm oil is sustainable -- it doesn't involve deforestation, endangering precious animal species, or forcing inhumane labor practices. The result is a world where consumers can enjoy the products they love without worrying about the dangerous practices involved in making them.

Caladan Bio is a Brooklyn-based startup specializing in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. The company's first product, the Caladan 250, is a high throughput benchtop bioreactor system that leverages AI and machine learning to enable advanced data capture and increase throughput. Caladan Bio is focused on revolutionizing the way biotechnology research is conducted by creating lower-cost, cutting-edge bioreactors and advanced software.

Founded in 1991 as Lucid Technologies, Inc. and later Lucid, Inc., Caliber I.D. offers in-vivo confocal microscopes designed specifically for imaging skin and other tissue. Caliber I.D.Õs Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye.

Casana is innovating healthcare delivery with a smart toilet seat that enables effortless, integrated, and consistent in-home health monitoring. The FDA-cleared Heart Seat® captures heart rate and blood oxygenation. The healthcare system has been searching for this actionable intelligence for decades, and it turns out, we were sitting on a great idea all along. The Heart Seat will become commercially available upon future clearance of non-invasive blood pressure.

CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.

CD ComputaBio is a professional computational biology service company. Our service spans across different areas in computational biology, providing access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. We are committed to providing high-quality data and customer service to various industrial and academic customers.

CD Genomics is aiming at providing the research community with high quality Next Generation Sequencing, high throughput microarray services. Due to the demand for our services has being increased; CD Genomics has already updated its technology platform to mainstream NGS and microarray instruments. At present, our senior bioinformaticians have ever viewed more than ten thousands of trace files and accumulated abundant experience with our Illumina HiSeq2000/2500, Illumia Miseq, Ion Torrent PGM, PacBio RS and ABI 3730/3730XL analyzers. We continue to work hard to offer you the same dependable services to pharmaceutical and biotech companies, as well as academia and government agencies for the purpose of satisfying all your sequencing or array needs. In 2007, CD Genomics has expanded its services to molecular biology research and its development needs. We have become a service provider in sequencing, microarray analysis, library construction and genotyping. Our progress could not be achieved without our large group of client's support. Through nearly ten year's hard working and depend on our professional work team, we are proud of satisfying the needs of our clients both at home and abroad, which across more than 50 countries and districts. We always devote ourselves to providing you with the best and professional service.

Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Celmatix’s proprietary multi-omic ovarian health platform, the world’s largest of its kind, is the foundation of the company’s novel pipeline of first-in-class therapies. For more information visit www.celmatix.com.

At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation of human-centric healthcare, by transforming research, and advancing health together. Uniquely, we combine the experience of specialty laboratories with the global reach of a central lab. We have a worldwide network of 1000 labs, hold data from over 85 million patients across five continents, and have the ability to sequence 1000-plus whole human genomes per week. This unparalleled approach to patient data gives you the opportunity to have one partner for all your test services, with consistent access and support across all clinical trial phases.

About Chembio Diagnostics: Chembio is a leading point-of-care diagnostics company focused on creating fast actionable tests to diagnose diseases quickly and accurately, including STIs and COVID-19, enabling expedited treatment. Chembio tests are easy to use and provide results in approximately 15 minutes using some of the smallest sample sizes of fingertip blood, nasal swabs and other sample types. Chembio recently received FDA CLIA Waiver for the first rapid point-of-care combination test for HIV & Syphilis. Coupled with Chembio's extensive scientific expertise, its novel DPP® technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. Learn more at www.chembio.com. About the DPP Rapid Test Platform: Chembio's proprietary DPP® technology platform provides high-quality, rapid diagnostic results in 15 to 20 minutes using a small drop of blood from the fingertip or alternative samples. Through advanced multiplexing, the DPP platform can detect up to eight, distinct test results from a single patient sample, delivering greater clinical value than other rapid tests. For certain applications, Chembio's easy-to-use, highly portable, battery-operated DPP Micro Reader optical analyzer then reports accurate results in approximately 15 seconds, making it well-suited for decentralized testing where real-time results enable patients to be clinically assessed while they are still on-site. Objective results produced by the DPP Micro Reader reduce the possibility of the types of human error that can be experienced in the visual interpretations required by many rapid tests.

Chemeleon has created a platform technology for the rapid, instrument-free, detection of chemical compounds in the field, obviating the need for slow, complex, and expensive lab analysis. Our sensor materials combine highly selective molecular receptors with colorimetric nanomaterial reporters to provide an autonomous and inert means of optically detecting hazardous chemicals in virtually any environment, from clinical to third-world settings.

Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.

Clarapath is a medical robotics company automating the laboratory. Our first product is focused on automating the microtomy station in pathology. Our vision is to innovate, standardize, and digitally transform anatomic pathology through higher quality lab medicine, more robust safety standards, increased lab throughput, while lowering laboratory costs and labor related delays.

Clinilabs Drug Development Corporation is a contract research organization (CRO) that provides clinical drug development services to industry. We are experts in CNS drug development. Clinilabs provides first-in-human through end of phase 3 services, with a global core laboratory. It is an alternative to large CROs providing a full spectrum of offerings to meet the needs of our customers world wide. Since 2000, Clinilabs has completed more than 675 clinical trials, and has worked for 15 of the top 20 pharma companies in the world, to contribute to 19 successful new drug applications (NDAs).

https://www.comprehensivecellsolutions.com/contact/ Comprehensive Cell Solutions (CCS), is a business division of the New York Blood Center Enterprises, created to meet the needs of academic institutions, hospitals, biotech, pharmaceutical and startups organizations to launch new products, services, and perform clinical trials. CCS makes clinical and research challenges simple by leveraging NYBCe’s world-class expertise and experience in clinical trials management, regulatory and accreditation history. To date, CCS has: • Collaborated with early stage companies to co-develop innovative products. • Collaborated with diverse business entities and academic institutions to manage clinical trials, assist with budget, contracts, IRB submission, FDA submission, and invoicing. • Initiated and participated in national and international clinical trials. Comprehensive Cell Solutions seeks to expand its loyal customer base by offering an extensive suit of R&D products and services that have been designed to seamlessly facilitate partnerships, innovation support, and joint-ventures. CCS is quickly on its way to becoming a world renown pioneer of research and development in new generations of blood and cell-based therapies that address critical, unmet patient needs. Did You Know? • The CCS team has reviewed and overseen hundreds of research projects, preclinical and clinical studies? • CCS is a subject recruitment expert with access to hundreds of thousands of normal, healthy donors for most clinical trial studies? • CCS provides consultation on FDA requirements, certification and 510(K) application, technical performance, and improvements and adaptations to meet and exceed FDA certification requirements? • CCS has a plethora of ‘Ready to Ship’ and ‘Made to Order’ products available with one-click of a button? Contact us now to learn more about how we can support your endeavors https://www.comprehensivecellsolutions.com/contact/

COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real-world data. By using our proprietary technology, advanced analytics and deep expertise to organize complex data, we provide a comprehensive picture of cancer that can be used to advance care and research. ‍We believe that everyone touched by cancer deserves a clear path to care. Together, we can make that vision a reality.

Courier Health is a New York City-based technology company on a mission to improve the patient experience for the millions living with rare diseases and to provide a purpose-built patient CRM for life sciences. They develop a patient engagement platform designed to deliver personalized experiences from end to end.

Creative Bioarray uniquely pioneers the development of high quality tissue, antibody, protein and cell array technology to efficiently analyze the concurrent expression and function of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample. Creative Bioarray is a well-recognized service provider propelled by integrity, expertise and the desire to contribute to simplify, improve, and accelerate research speed of the scientists by providing the highest standard quality research products and services. Since it founded, Creative Bioarray had recognized that an important obstacle to make development of basic bioscience and preclinical researches using human specimens is the lack of access to reference materials. Consequently, Creative Bioarray was determined to be the first commercial entity specialized in building up the largest tissue-sharing platform by integrating the detailed clinical information of all the tissue samples.

Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early drug discovery and drug development. As a trusted provider of the most cost-effective outsourcing solutions, Creative Biolabs has been working for a large number of satisfied clients from biotechnology and pharmaceutical companies as well as government and academic research laboratories all over the world. Creative Biolabs was founded by scientists who are dedicated to the conquering of cancer. We believe to build up a custom-service-centered business model is important for optimizing the drug development process, leveraging accessible resources, and forming a team of various background to conduct drug discovery in future. Our commitment to this long-term goal motivates us to deliver the highest quality results to our clients with speed. Specialties: Protein Production, Hybridoma, Immunoassay, Tissue Array, Antibody Engineering, Other Services Check out our current job openings: https://www.creative-biolabs.com/career/available-positions.aspx

Starting from a small supplier of proteins and enzymes for academic institutes and biotech companies, Creative BioMart has always been focusing on developing high quality protein products and efficient protein manufacturing techniques. Over the past decade, our products and services are proved to have served our customers well and our brand has become one of the most trustworthy in the market. * More than 5,000 recombinant protein products in stock *Scientific expertise *Advanced CRO services *Reliable supplier and partner *Worldwide network of distributors *Highly-customized solutions

Creative Biostructure is specialized in providing cost-effective contract services to both academia and biotech/pharmaceutical industries in the field of structural biology and membrane protein technologies. We have developed all-in-one, gene-to-structure pipelines for the structure determination of macromolecules of your interest. With a team of experienced professionals, Creative Biostructure is able to solve the structure of many challenging proteins including GPCRs, ion channels, transporters, enzymes and viral targets. We also provide a comprehensive list of products and other related services to facilitate your research in structural biology. Creative Biostructure has also built up a unique and comprehensive Membrane Protein Screening Platform. Aiming at elucidating the fundamentals of membrane protein systems, we provide gene-to-structure services on the purification, crystallization, structure determination and analysis of various membrane proteins. With our state-of-the-art platforms, we are offering our customers access to the latest tools, techniques and expertise for their structural biology projects with competitive pricing and short turnaround time. Our staff will be very glad to discuss the details of your project and develop experimental strategies tailored to your requirements.

Creative Diagnostics is a biotechnology company based in Shirley, New York, specializing in diagnostic reagents and contract research services. Established in the early 2000s, the company serves global markets in biopharmaceuticals, diagnostics, and academic research. With a team of 25 to 200 employees, Creative Diagnostics generates an estimated annual revenue of $5 million to $25 million. The company offers a range of products, including research-grade and therapeutic antibodies, viral antigens for vaccine development, customizable ELISA kits, rapid test kits, and specialized reagents for gene therapy and bioanalysis. Creative Diagnostics also provides contract assay development, GMP manufacturing for biologics, and custom antibody development through its proprietary Omni-Hybridoma™ platform. Its technical capabilities support rapid commercialization and are particularly relevant for mRNA vaccine development and therapeutic drug monitoring.

Creative Genomics(CG) specializes in providing the services of DNA sequencing, genotyping and library construction in the global market. Our state-of-the-art sequencers including ABI3730xl, Roche 454 GS-FLX System and Illumina Solexa 1G Genome Analyzer make our customer-oriented DNA sequencing services to stand out with efficiency, reliability and flexibility. Coupled with a variety of high definition genotyping platforms such as Illumina BeadStation 500, Beadxpress and Sequenom, a full range of services from whole genome scans to targeted SNP genotyping can be provided with a high turnover rate. In addition, theyhave professional team members with extensive experience in library construction. Above all these, an in-house Laboratory Information Management System (LIMS) as well as manual basecalling by senior bioinfomaticians ensuresservices with the highest quality.

Creative Peptides is specialized in the process development and the manufacturing of bioactive peptides. They offer custom peptide synthesis, process development, manufacturing as well as catalog products for customers in industry and research area.

Creative Proteomics has gradually developed into an integrated company that provides proteomics, metabolomics, glycomics, and bioinformatics analysis services to researchers in the pharmaceutical, biotechnology, agriculture and nutrition industries, as well as academic and government organizations. With a continuing focus on quality, we are proud of satisfying the needs of our clients both at home and abroad covering more than 50 countries and districts.

Curie Co fashions biological solutions from the basic building blocks of life. Curie Co’s enzyme optimization platform teaches abundant, naturally-occurring enzymes to perform the same function as legacy preservatives and with efficiency that is orders of magnitude better. Our enzymes are gentle for people and the planet–they are fully biodegradable and sustainably derived. From hand soap, body wash, hair care products, skincare, and beyond, we give product formulators the freedom to build a powerful, long-lasting product that is nature-based from the bottom up. Founded in 2017, Curie Co is a collection of top scientists from Fortune 500 companies around the globe. Our interdisciplinary team unites under the belief that sustainability is not a luxury, it’s our obligation. Curie Co is proudly based in Research Triangle Park. To learn more, please visit: https://www.curieco.com/.

Duality's breakthrough innovative technologies eliminate the conflict between data protection and business growth and innovation. The Duality Data Analytics and AI platform is built upon advanced encryption methods, hardware technologies, and machine learning techniques that protect sensitive data while in use. Duality is the only multi-PET platform with the ability to combine various technologies to meet the unique needs of sensitive data operations. These guardrails streamline and enhance the data operations critical for data-driven insights and innovations by eliminating bulky, expensive, and limiting processes like data anonymization and tokenization. Traditional data protection methods prevent organizations from truly adopting and leveraging advanced models to their benefit, resulting in restrictive policies like "no sensitive data can be used for model training." With Duality, organizations can confidently customize 3rd party models on their own data without fear of data leaks. Model providers can scale model customization knowing that their proprietary model is never exposed to the customer, preventing competitive intelligence leaks. Financial institutions can turn their manual KYC requests into self-service operations, greatly enhancing the speed and success of these expensive requirements. The benefits of data protection guardrails span from efficiency gains, to unlocking previously inaccessible data, to slashing costs on high-security infrastructure.

Founded in 2006, eHealth Technologies is the industry-leading provider of clinically informed referral services. We serve more than half of the nationÕs top 100 hospitals, including 16 of the top 20 U.S. News & World Report Honor Roll Hospitals for 2016-2017, and leading health information exchanges (HIEs) across the United States. The companyÕs eHealth Connect¨ solution enhances patient and physician satisfaction by streamlining referrals and intelligently aggregating patientsÕ clinical records. This assures physicians have the right healthcare information to care for their patients, right when they need it. As a critical adjunct to HIEs, eHealth Connect¨ Image Exchange enables the automated access to all types of medical images in the context of the aggregated patient record, in full diagnostic quality, and supports the ability of providers to meet Meaningful Use Stage 2 requirements.

Embleema's software platform brings precision medicine sooner to patients by collecting and generating regulatory-grade evidence. Our platform natively unifies clinical, molecular and real-world data and is the sole one used by the FDA for its regulatory evaluation of health products involving genomic datasets. The protocols and algorithms contained in our platform are also the basis for future CDISC standards for cell and gene therapies. The FDA also uses our platform to produce regulatory grade genomic sequences for SARS-CoV-2 and other microbial pathogens (project ARGOS). In addition to the FDA, our platform powers the Lupus Landmark Study, the largest clinical study for lupus in the world, the Human Epilepsy Projects and tens of other clinical studies for pharmaceutical companies, biotechs and patient groups. More than half of the top 10 Investigational sites in the US use our platform: John Hopkins, NYU, UCSF, Yale, UPenn, Washington University in St Louis, Cornell and many others also such as Mayo Clinic, Yale, Georgetown.

Empire Genomics is a leading biotechnology company focused on the development of advanced molecular diagnostics and genomic products. Our mission is to accelerate precision medicine by providing tools that empower researchers, clinicians, and pharmaceutical companies to better understand, diagnose, and treat complex diseases, particularly in oncology. We offer an extensive portfolio of FISH (Fluorescence In Situ Hybridization) probes, ancillary reagents, and custom assay development services. These products are essential for detecting genetic abnormalities, such as gene amplifications, deletions, and rearrangements, critical for diagnosing and monitoring various cancers and genetic disorders. Committed to quality and innovation, our products are rigorously tested to meet the highest industry standards, ensuring reliable results. Selling products globally through a network of distributors, Empire Genomics continues to advance personalized medicine, enabling healthcare providers worldwide to deliver more targeted and effective treatments to patients.

For more than 45 years, Enzo Biochem has been a leader in innovation and product development to support a diverse range of needs in biomedical research and healthcare. With a comprehensive portfolio of 20,000 high-quality products including antibodies, genomic probes, assays, biochemicals, and proteins, Enzo supports the work of academic research centers and industry partners who are shaping the future of healthcare around the world. The company's proprietary products and technologies play central roles in all areas of translational research and drug development, including genomic analysis, protein analysis, cellular analysis, tissue analysis, and small molecule chemistry. Enzo Biochem has a broad and deep intellectual property port-folio, with patent coverage across a number of key enabling technologies.

EpiBone is a revolutionary bone reconstruction company that allows patients to "grow their own bone". EpiBone's pioneering technology utilizes a scan of the patient's bone defect and the patient's own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

We are on a mission to build a revolutionary cancer diagnosis platform to solve the challenge of early cancer prognosis and detection, as well as prediction of post-diagnosis cancer drug response.

EvolutionaryScale is a biotech startup focused on AI research in the field of biology. The company has developed a database of over 2 billion protein sequences to train its AI model, offering technology that can provide insights into biological processes. EvolutionaryScale has raised significant funding, including a $142 million seed round, and is known for its ESM3 Generative AI Model for biology.

Evvy is unlocking precision women's healthcare through novel, overlooked female biomarkers — starting with the vaginal microbiome. Backed by leading healthcare investors such as General Catalyst, Left Lane Capital, and LabCorp, the Evvy team includes leading OB/GYNs and vaginal microbiome researchers with decades of experience at organizations like UCSF, Stanford, Harvard, Cleveland Clinic, and more. Evvy is one of the fastest growing women's health companies in the US — enabling us to deliver innovative, high quality care while scaling novel R&D to unlock a new, data-driven future in women's health. Evvy's Vaginal Health Test is the first at-home vaginal microbiome test to use metagenomic sequencing to tell you what's up down there, why it matters, and what you can do about it. Evvy's larger platform is the first vaginal healthcare service to bring together state-of-the-art testing, precision clinical care, and 1:1 coaching to give women and people with vaginas the care they deserve. Through this platform, Evvy is building real-world datasets that can transform our understanding of complex female health conditions. Imagine a world where female health is finally understood: where risks are detected early and precisely; conditions are defined with specificity and nuance; and diseases are treated with personalization and care. That's the world that Evvy is pioneering.

EXO is the pioneer behind the consumption of insects as a nutritious and sustainable alternative protein source. In simple terms: we create delicious protein-forward foods with Acheta Protein at their core, making them are good for your body and the environment. Our products are Dairy-Free, Gluten-Free, All-Natural, and Sustainably Produced. We have been featured in The New York Times, Business Insider, Forbes, National Geographic, TechCrunch, The Wall Street Journal, Fast Company, Greatist, Mark's Daily Apple, RYOT, PSFK, The Daily Meal and much, much more. Web: http://www.exoprotein.com Facebook: http://www.facebook.com/exoprotein Instagram: http://www.instagram.com/exoprotein Twitter: http://www.twitter.com/exo_protein

Welcome to the future of neurological assessments with Firefly Neuroscience’s FDA-cleared Brain Network Analytics (BNA™). Utilizing ADVANCED AI and an extensive proprietary EEG database, BNA™ combines the automatic analysis of Event-Related Potentials (ERPs), spectral EEG, and behavioral performance data for a comprehensive and objective data-driven brain health evaluation.

ForkandGoodeis a cellular agriculture company working to develop cell-​based meat.

FOXG1 Research Foundation (FRF) is a US-based 501(c)(3) not-for-profit dedicated to accelerating research to find a cure FOXG1 syndrome. Previously called Brain Factor 1, FOXG1 is one of the first and most fundamental genes formed during brain development. Most children with FOXG1 syndrome cannot walk, talk, crawl, or take care of their most basic needs; most have a feeding tube, most undergo major surgeries, and most suffer from life-threatening seizures. Many leading neuroscientists believe that FOXG1 holds the key to unlocking many brain disorders that affect millions of people including autism, schizophrenia, Alzheimers and brain cancers. They also believe FRF can get to human clinical trials in three to five years. The FOXG1 Research Foundation was founded by FOXG1 moms in 2017 with the support of a worldwide team of FOXG1 parents. FRF is quickly becoming known in the biotech arena as a Patient Organization making tremendous strides. FRF raised more than one million dollars in less than one year and has successfully funded six major research projects fostering the most comprehensive study of FOXG1 to-date. The potential to improve millions of lives is tremendous. The time is now. Join us to pioneer some of the most ground-breaking research in human history. 1 www.foxg1research.org

Gencove creates high-volume, cost-sensitive sequencing software-as-a-service to help academic, agriculture, biotech, diagnostic, and pharmaceutical companies get all the genomic information they need to make life-saving discoveries.

Glycotest is Creating the New Clinical Standard for Early Diagnosis and Surveillance of Liver Cancer

Harter Secrest & Emery LLP is a full-service business law firm providing legal services to clients ranging from individuals and family-owned businesses to Fortune 100 companies and major regional institutions. With offices in Buffalo, Rochester, Albany, Corning, and New York City, New York, the firm is a recognized leader in litigation, corporate, employee benefits, environmental and land use, health care, higher education, immigration, intellectual property, labor and employment, real estate, and trusts and estates law. The firm and its attorneys are consistently recognized by the industry's leading law firm and attorney ranking programs, including Chambers and Partners, Best Law Firms® and The Best Lawyers in America®.

The Interactive Advertising Bureau (IAB) empowers the media and marketing industries to thrive in the digital economy. Its membership comprises more than 700 leading media companies, brands, agencies, and the technology firms responsible for selling, delivering, and optimizing digital ad marketing campaigns. The trade group fields critical research on interactive advertising, while also educating brands, agencies, and the wider business community on the importance of digital marketing. In affiliation with the IAB Tech Lab, IAB develops technical standards and solutions. IAB is committed to professional development and elevating the knowledge, skills, expertise, and diversity of the workforce across the industry. Through the work of its public policy office in Washington, D.C., the trade association advocates for its members and promotes the value of the interactive advertising industry to legislators and policymakers. Founded in 1996, IAB is headquartered in New York City.

Virology research products

Inso Biosciences is an early-stage biotechnology company developing hardware platforms and tools for genomic sample handling. Our patented microfluidic technology, invented and developed at Cornell University, performs high-efficiency processing of cellular material, and we are exploring applications in long-read DNA extraction, multiomic sample processing, and pathogen surveillance. To find out more, please visit our website: www.inso.bio To get in touch with us, please email: contact@inso.bio

iuvo BioScience is a contract research organization serving the pharmaceutical and medical device industries. Our services encompass pre-clinical research, clinical research and consulting services. With a focus on safety and biocompatibility, iuvo provides assistance through the full product development life cycle, from research to release, including ISO 10993:2018 testing as well as testing programs and advisory services to support regulatory submissions. We have an AAALAC-accredited vivarium and offer full service, GLP-compliant toxicology testing, as well as microbiology and analytical chemistry testing laboratories. We are certified to ISO 13485:2016 and accredited to ISO 17025:2017 quality system standards. We bring decades of experience supporting healthcare and medtech companies of all sizes from around the world, and we work closely with our customers to deliver exquisite science, reliably and on time. Come to us with a specific test, a full program you need managed, or even a research question you need help answering. We are your Partner Research Organization.

Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.

Lake Immunogenics was founded in 1985. Animal health and ethical treatment are our passions. Our benchmark plasmapheresis process allows large volume production of polyclonal antibodies without compromising the donor animal. From initial offerings of custom polyclonal antibodies, the business expanded to the equine therapeutic market. RhodococcusEqui Antibody (Pneumomune-Re), Equine IgG (HiGamm Ð equi) and Plasmune plasma products for foal health are the cornerstones of our therapeutic products. Today, the facilities include research and development laboratories, production rooms with walk in freezer capacity and a 155 acre farm that is home to closed herds of horses, steer, llamas, and goats. Lake Immunogenics continues to provide custom polyclonal antibodies and is select agent registered with the CDC. Our veterinary therapeutics have expanded beyond equine products to include plasma products for camelids, bovine and goats. Lake Immunogenics also provides high quality animal blood products as starting material for further biologics manufacturing and for research and development. In 2011, Lake Immunogenics Inc. added large animal preclinical studies to our service offerings. In 2013 we began providing accredited housing for long term study animals. Bovine plasma was introduced in 2015

Leep Foods utilizes regenerative farming methods to grow premium organic mushrooms on nutrient-rich American hardwoods for consumers and restaurants to enjoy any time of the year.The company is also known asEmpire Medicinals.

LetsGetChecked is a virtual care company that allows customers to manage their health from home, providing direct access to telehealth services, pharmacy, and laboratory tests with at-home sample collection kits for a wide range of health conditions including Sexual Health, Cholesterol, Diabetes, Thyroid, Coronavirus (COVID-19), and more. Founded in 2015, the company empowers people with the care they need to live longer, happier lives. Today, LetsGetChecked is a leader in healthcare innovation with an end-to-end model including manufacturing, logistics, lab analysis, affiliated physician support, and prescription fulfillment, which provides a seamless user experience and a convenient, reliable and secure healthcare experience. LetsGetChecked is available nationwide in the United States and most EU countries. It is co-headquartered in Dublin and New York, with teammates all over the world. To learn more visit www.letsgetchecked.com.

LifeNome's AI algorithm looks at 9000+ genetic variations holistically (rather than other companies that look at single gene associations)to assess your overall predispositions for nutrition, fitness, skin care and many more wellness traits.​

Lilu, Inc. is a women's health company based in New York, founded in May 2016. The company specializes in tech-enabled products that support new mothers during postpartum care. Lilu focuses on making breastfeeding, pumping, and early motherhood more efficient and comfortable. Their team of four has developed patented pneumatic massage technology to help address lactation challenges. The flagship product, the Lilu Massage Bra, is the first automated breast massage pumping bra. It uses compression massage technology to enhance milk output during pumping sessions. Additionally, Lilu offers the MilkSense App, currently in beta, which helps mothers track breast milk production and optimize their feeding routines. Lilu emphasizes user-centered design and aims to empower mothers through innovative solutions that improve postnatal care.

Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 40 million Electronic Health Records. Clinical trials are the biggest bottleneck to advances in healthcare. Lindus Health removes this constraint through end-to-end execution of clinical studies driven by technology and forward-thinking approaches to clinical operations.To date, Lindus Health has delivered clinical trials across the US, UK and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company has raised over $80M from investors including Peter Thiel, Balderton, Creandum, Firstminute Capital, and Seedcamp.

LineaRx, an Applied DNA Sciences, Inc. company (NASDAQ: APDN) delivers enzymatically-produced LinearDNA™ as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity and scalability to support the next generation of nucleic acid-based therapies. Manufactured by a proprietary, large-scale polymerase chain reaction (“PCRâ€?) based manufacturing platform, LinearDNA allows for the rapid and efficient cell-free production of high-fidelity DNA sequences.

Litron has spent the last 40 years providing critical data to pharmaceutical, medical device, government and contract research organizations around the world. With a laser focus on DNA damage and other toxic effects, we develop state-of-the-art flow cytometric methods to solve challenging problems for the toxicology industry.

LSI SOLUTIONS®, located in beautiful Victor, New York, is a dynamic and growing medical device company that has more than doubled in size over the last seven years. - LSI SOLUTIONS® is dedicated to advancing minimally invasive therapeutics through research, development, manufacturing, and marketing proprietary products. - Company Mission: Our customer is ultimately a patient. Our technology challenges human illness. Our mission is to lead the world in surgical innovation and product delivery.

American Regent, Inc, a Daiichi Sankyo Group Company, develops, manufactures, and supplies high quality sterile injectables for healthcare providers, clinics and hospitals across the United States and Canada. We have locations in New York, Ohio, and Pennsylvania and sales territories nationwide. American Regent continues to position its business for sustainable growth, with significant investments in the modernization and expansion of our U.S. manufacturing sites. These enhancements are expected to strengthen our business and represents our commitment to the ongoing success of our company and its employees. Supporting patient health is our guiding principle and our promise is to provide the healthcare marketplace with a steady supply and broad portfolio of brand and generic specialty injectables.

Massive Bio collects and curates the latest scientific knowledge in genomics of cancer, connects with clinical information incorporate all new discoveries in treatment plans.

Matexcel is a service provider in materials science, with years of commitment to supply better polymers, nanoparticles and other materials for worldwide customers from both academia and industry. They offer a full range of materials covering polymers, metals, ceramics and natural materials, in addition to professional consultation service in manufacturing and characterization. Our experienced team of scientists have mastered a wide spectrum of technologies to solve interdisciplinary tasks such as custom synthesizing and developing polymeric and nano-bio applications. They are a customer-oriented company aiming to deliver product and service to the global pharmaceutical and nano-biotechnology markets.

Matter Bio is a longevity holding company focused on preserving genome integrity As we age, our genome is constantly being damaged by exogenous and endogenous sources. Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss. At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome. To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.

Mercer University is a higher education institution offering a variety of academic programs and degrees.

Millennial Scientific manufactures sustainable separation and purification materials for the discovery, R&D, and manufacturing of pharmaceuticals and other chemicals. Our product portfolio includes the award-winning NanoPak-C all-carbon suite of chromatography products. These products enable economical (e.g., operation cost reduction) and better (e.g., yield improvement) performance. These products are available as bulk stationary phase media or packed in solid-phase extraction (SPE) and liquid chromatography columns. We are ISO 9001:2015, MBE (New York State (NYS)), and DBE (Metropolitan Transportation Authority (MTA)) certified.

Diagnostics We build innovative diagnostic and monitoring tools that empower people to make better decisions about their health. Drug Discovery We translate early-stage research into customized RNAi and CRISPR Cas9 animal and cell models to accelerate drug development. Therapeutics We identify and validate new drug targets, unleashing the commercial potential of RNAi to benefit people on a global scale. Established in 2010 to harness the power of RNAi and genetic engineering technologies developed by our founders in the labs of the world's leading experts at Cold Spring Harbor Laboratory, Howard Hughes Medical Institute, and Harvard Medical School, Mirimus creates innovative research and clinical technologies to address health issues on a global scale. Today, Mirimus markets multiple unique and high-value drug discovery and diagnostic products and services, and is advancing a pipeline of therapeutic candidates in partnership with leading biopharma companies to create novel high-impact health care solutions that benefits society on a global scale. Mirimus' ability to leverage its cutting-edge science and proprietary technology platforms to rapidly create new, affordable technology and products at scale is core to the way we work. We embrace diversity and creativity and have a proven track record of innovative problem solving—which led to our recognition as a $1M grand prize winner of the XPRIZE competition by developing a radically affordable, rapid, non-invasive methodology for mass COVID-19 testing—driving us to make better drugs and detect disease earlier. At Mirimus, our ingenuity, respect for our colleagues' ideas and creativity, executional agility, and a commitment to global health equity combine to create a unique culture of innovation that delivers measurable progress.

Mispro's contract vivarium (CV) solution offers emerging, mid-sized, and even mature biopharma companies access to state-of-the-art vivarium research facilities and laboratory animal services for preclinical drug discovery and development. Our space plus services model enables founding scientists and research teams to keep in in vivo rodent studies in-house without having to incur the costs and operational complexities of internalizing a vivarium facility.

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care. WHO WE ARE We are compassionate collaborators—38,000 strong—working to heal, teach, and advance medicine in New York City and throughout the world. WHAT WE BELIEVE We believe in challenging the status quo. Forging a new pathway in clinical excellence is only possible by putting the patient at the center of the experience. WHY WORK WITH US Here, innovation is valued and collaboration is integral. Mount Sinai is full of friendly, helpful people who share a common devotion to delivering exceptional patient care. Yet we’re as diverse as the city we call home—culturally, ethnically, in outlook and lifestyle. When you join us, you become part of Mount Sinai’s unrivaled record of achievement, education, and advancement as we revolutionize healthcare together.

Nalge Nunc International is a distributor and manufacturer of plastic laboratory containers that has diversified into the field of containers for outdoor sports and packaging materials

We make sure great products get made. Too many great product ideas never get made. Natech ensures our clients' innovative ideas are manufactured so they can get started on their next great idea. As an injection molder and contract manufacturer, Natech specializes in an engineering-focused approach to manufacturing. Our core team are experts in design for manufacturing, assembly and scaling new products. Natech is an ISO 9001, ISO 13485 and FDA-registered molder. Headquartered in Long Island, NY, Natech operates three facilities, including a class 8 cleanroom for medical molding and assembly. Natech Plastics serves the medical, diagnostics, electronics, consumer goods and packaging markets. Contact a Natech engineer to get started on your new product.

Nebula Genomics is a genomics company that offers genome understanding, disease cure assistance, and data ownership through blockchain technology.

Neural Stem Cell Institute is a regenerative medicine company that focuses on developing stem cell therapies for diseases of the nervous system.

Clean energy can power New York while protecting the environment. The New York State Energy Research and Development Authority, known as NYSERDA, promotes energy efficiency and the use of renewable energy sources. These efforts are key to developing a less polluting and more reliable and affordable energy system for all New Yorkers. Collectively, NYSERDA’s efforts aim to reduce greenhouse gas emissions, accelerate economic growth, and reduce customer energy bills. NYSERDA works with stakeholders throughout New York including residents, business owners, developers, community leaders, local government officials, university researchers, utility representatives, investors, and entrepreneurs. NYSERDA partners with them to develop, invest, and foster the conditions that: ✅ Attract the private sector capital investment needed expand New York’s clean energy economy ✅ Overcome barriers to using clean energy at a large-scale in New York ✅ Enable New York’s communities and residents to benefit from energy efficiency and renewable energy Governed by a 13-member Board, NYSERDA has provided objective information and analysis, technical expertise, and support in New York State since 1975. Our Vision: New York is a global climate leader building a healthier future with thriving communities; homes and businesses powered by clean energy; and economic opportunities accessible to all New Yorkers. Our Mission: Advance clean energy innovation and investments to combat climate change, improving the health, resiliency, and prosperity of New Yorkers and delivering benefits equitably to all. Our Promise: NYSERDA provides resources, expertise, and objective information so New Yorkers can make confident, informed energy decisions. Visit nyserda.ny.gov/careers to learn about career opportunities.

Nixon Peabody LLP is an American Lawyer top-100 law firm in the United States and has 15 offices worldwide. Our firm delivers exceptional service to our clients and our communities by combining high performance, entrepreneurial spirit, deep engagement, and an unwavering commitment to a culture of collaboration, diversity, and humanity.

NovaSterilis is the global leader in the development and manufacturing of supercritical carbon dioxide (scCO2) processes for biomaterials and medical devices, including the decellularization and sterilization of allograft and xenograft tissues. NovaSterilis' scCO2 technologies exceed the highest standards for product safety and performance. These processes have been used to treat ortho/dental/spinal products used in over 300,000 surgeries over the past 8 years. scCO2 involves lower temperatures (31°C) and pressure above 1100 psi. This lower temperature makes scCO2 ideal for materials that are temperature sensitive or reactive with other forms of sterilization. scCO2 can penetrate and sterilize delicate products and materials, such as allograft tissue, without damaging the product's structural or chemical integrity. NovaSterilis serves a variety of markets, including complex medical devices, drug delivery, tissue engineering, biotherapeutics/API, and additive manufacturing. With NovaSterilis, you can count on a sterility assurance level 10-6, an environmentally friendly solution, shorter turnaround times, and more. Protect and differentiate your products with supercritical CO2.

Nucleus is the all-in-one DNA health test. We combine whole-genome sequencing — which analyzes nearly all your DNA — with your unique lifestyle factors, delivering the most comprehensive look into your health and well-being that's ever been available. With deeper insights, Nucleus empowers you to live your healthiest life.

Founded in 1831, NYU is one of the world's foremost research universities and is a member of the selective Association of American Universities. The first Global Network University, NYU has degree-granting university campuses in New York and Abu Dhabi, and has announced a third in Shanghai; has a dozen other global academic sites, including London, Paris, Florence, Tel Aviv, Buenos Aires, and Accra; and sends more students to study abroad than any other U.S. college or university. Through its numerous schools and colleges, NYU conducts research and provides education in the arts and sciences, law, medicine, business, dentistry, education, nursing, the cinematic and performing arts, music and studio arts, public administration, social work, and continuing and professional studies, among other areas.

One Drop is a precision health company combining continuous diagnostics, predictive analytics and machine learning in an award-winning digital solution to deliver cost-saving outcomes for people living with diabetes and other chronic conditions. The goal: empower everyone to take proactive action for better health, peak performance, and more fulfilling lives.

Opentrons Labworks, Inc., is a disruptive life science company leveraging its integrated lab platform to supercharge the pace of innovation in research and healthcare. Opentrons Labworks is the parent company to business units Opentrons Robotics and Neochromosome. Through Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use liquid handling lab robots. Through Neochromosome, biopharma and biotech at large can benefit from our world-class genome-scale cell engineering solutions. Opentrons Robotics, a business unit of Opentrons Labworks, Inc., is the industry leader in flexible, user-friendly automation for life science labs. Our open-source ecosystem offers the scientific community the tools they need to automate experiments, share protocols and reproduce each other's results. Opentrons robots can be found in thousands of academic, biopharma, synthetic biology and clinical research labs in more than 40 countries.

OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed's team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

Ordaos is a human-enabled, machine-driven drug design company that creates novel and customized mini-proteins. Their mission is to help biopharma partners deliver life-saving treatments by creating bespoke mini-proteins to aid drug hunters.

Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists' workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn more about Paige: https://www.paige.ai

Our global associates are unified by a singular drive: to take on our customers’ biggest challenges. To solve the critical problems that stand in the way of advancing health, safety and the environment. Where others see something that can’t be done, we jump in fully committed to do it. We push the limits of science and technology. We redefine partnership through deeper, more meaningful collaboration. It’s how we’ve approached our calling since 1946. And why today you’ll find our filtration, separation and purification solutions at work in so many places. From life-saving gene therapies to airplane engines. Hydraulic systems to injectable medications. Scotch. Smartphones. OLED screens. Paper. Everyday Pall is there, helping protect critical operating assets, improve product quality, minimize emissions and waste, and safeguard health. No matter what, no matter where, we innovate and collaborate to deliver the one thing our customers need most: The unsolvable, solved. More here: http://www.pall.com. ******* Pall Corporation is proud to be part of Danaher. Danaher’s science and technology leadership puts Pall’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Incubated by ARCH Venture Partners and backed by leading healthcare and life sciences investors, Paradigm Health aims to break down barriers across the trial ecosystem through one seamless infrastructure implemented at healthcare provider organizations, bringing potentially life-saving therapies to patients faster.

PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

PLD is a leading supplier of over-the-counter solid and liquid dose remedies in the Analgesic, Cough/Cold, Allergy, Sleep/Awake/Motion, Digestive, Nutritional, First Aid, Electrolyte and Epsom Salt categories. We pride ourselves on delivering the highest quality product in the most cost-efficient manner possible. This includes adhering to cGMP and stringent FDA regulations, so every product we manufacture meets and even exceeds the industry's rigorous standards. Since we began in 1988, it is our unwavering commitment to excellence that has enabled us to grow to serve every major retailer in the U.S. and many around the globe. Today we remain at the forefront of the consumer healthcare industry with 1,000+ dedicated employees and more than 1,000,000 sq. ft. of state-of-the-art facilities across New York, California, Florida and South Carolina. Our Mission To provide high quality and affordable healthcare products that help people feel well through services that cultivate trust and confidence. We foster an environment where people are passionate about their work and the wellbeing of their communities. Our Vision To be the most respected, efficient, and reliable partner delivering healthcare products and services that improve People's Lives Daily. Interested in a career at PLD? Please visit: http://www.pldevelopments.com/careers/

Positron Corporation is a medical technology company that co-develops, manufactures, and sells state-of-the-art PET and PET-CT imaging systems and clinical services to nuclear medicine healthcare providers throughout North America. Positron specializes in the field of cardiac Positron Emission Tomography (PET) imaging, the gold standard in cardiac diagnostics. Positron's innovative PET/PET-CT technologies, clinical services and practice solutions enables healthcare providers to accurately diagnose coronary artery disease and improve patient outcomes while practicing cost effective medicine. Positron's Attrius® PET and NeuSight PET-CT imaging systems and distinct market position are substantial advantages unique to Positron will facilitate the adoption of cardiac PET and the growth of the nuclear imaging market. Positron will soon offer a state-of-the-art PET-CT 4D molecular imaging device in the Affinity PET-CT 4D 64-Slice. Positron's PET-CT(s) will enable nuclear cardiologists to utilize the full capabilities of molecular imaging and nuclear medicine. Positron's PET-CT systems will enable the Company to fully service and meet the demands of the vast oncology imaging segment of nuclear medicine. Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its co-developer, supplier, and R&D venture with Shenyang Intelligent Neuclear Technology Co a subsidiary of Neusoft Medical Systems. Positron was founded in 1983 and is based in Niagara Falls, NY.

Prime Discoveries develops rapid, novel diagnostics for emerging pathogen infections with a focus on cost effective, massively scalable and easily automatable assays. Prime leverages multiple patented advanced technologies in microbial diagnostics including RT-LAMP, Rapid PCR, and mNGS (Next generation sequencing) to enable samples to result in under 1 hour with minimal lab infrastructure and technical expertise. Prime's products are best in class for Covid, Influenza, Sexually Transmitted Infections and new drug resistant microbes. All of Prime's assays are locally developed in the United States and can serve millions of people. Founded in NYC in 2017, Prime's scientists have extensive backgrounds in microbiology, computational biology, lab automation and AI from Genentech, Cooper Genomics, Recombine, Phosphorus, and NYU. Prime is advised by leading experts in the fields of genomics and public health including Dr. George Church and Esther Dyson. Prime is supported by academic institutions, venture capital firms and angel investors including New York University, Charles Zegar, BoxGroup, Akron Fusion Ventures, Beresford Ventures, Cannonball Capital, Liquid 2 Ventures, Francois Nader (Moderna, Acceleron, Shire), Unshackled Ventures, Doberman Forward, and others.

Profacgen offers a full range of biopharmaceutical development and bio-manufacturing services that cover strategic consultancy,process development, cGMP manufacturing, and analytical development.

Prognos Health is a real-world data (RWD) company that unlocks the power of data to improve health. Prognos offers the leading managed RWD marketplace, accelerating the development and delivery of innovative therapies and improving health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. Prognos Health's platform provides a comprehensive and integrated view of patient health, enabling researchers, payers, and providers to make better decisions about care.

ProPhase Labs Inc. (Nasdaq: PRPH) ("ProPhase") is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We're revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach.

PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development. We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into the clinic. With an extensive portfolio of highly predictive disease models and unparalleled experience performing studies for biopharmaceutical companies of all sizes, we enable clients to deliver much needed superior clinical candidates to patients. Our capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. We offer a variety of validated mouse models including in-licensed transgenic models that support research in areas such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy and a broad array of pain models.

Quantile Health is solving the problem of patient access to transformative treatments with an innovative new payment model.

A healthcare software company developing artificial intelligence (AI)-powered solutions, RADLogics provides machine learning image analysis solutions to improve radiologists' productivity while enhancing patient outcomes. Based in New York, NY, US, and Tel Aviv, Israel, RADLogics is one of the pioneers in using AI & machine learning image analysis and advanced big data analytics to search and analyze imaging data from CTs, MRIs, PET scans, and X-rays to help reduce diagnostics turnaround time from hours to minutes by automating detection and report generation functions. The company's patented AI medical image analysis platform enables rapid development of AI algorithms, and provides seamless integration into existing radiology workflow.

Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique Hôpitaux de Paris and INSERM protecting the Rarecells® Device and its consumables, as well as the analyses performed on cells isolated using the Rarecells® System. Rarecells® Diagnostics is a science-driven company. We are scientists working for scientists and patients. We care about bringing benefits to the patients.The team delivers customer satisfaction by manufacturing high quality products and providing high-level scientific assistance. Rarecells® and ISET® are registered trademarks of Rarecells SAS.

We are developing a novel device to prevent infection in peritoneal dialysis, a form of at-home treatment for end-stage renal disease. By minimizing the risk of infection, we enable more patients with kidney failure to receive quality care in the comforts of their own homes.

Renalytix is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease.COVID-19: Renalytix has entered into a joint venture with the Icahn School of Medicine at Mount Sinai (“Mount Sinai”), Kantaro Biosciences, LLC (“Kantaro”), to develop and scale production of COVID-19 antibody test kits.

Retia Medical develops and sells advanced algorithms and monitors for guiding care for high-risk surgical and critically ill patients. The Argos Cardiac Output Monitor provides consistent accuracy using Multi-Beat Analysis(TM), rapid setup, and an intuitive user interface while avoiding costly proprietary disposables. Approximately 20 million surgical intensive care patients worldwide could benefit from this technology. Based in White Plains, NY, Retia's technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients.

Microfluidics for Molecular DiagnosticsCOVID-19: (12/2020) EUA for COVID-19™ MDx Assay

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly - directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson’s Imbruvica, Astellas’ and Pfizer’s Xtandi, Biogen’s Tysabri, Johnson & Johnson’s Tremfya, Gilead’s Trodelvy, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates.

Sabai Design is the home design company furnishing a greater future.

SandboxAQ is harnessing the exponential power of AI + Quantum (AQ) technology. The inspiration for SandboxAQ and some of the team originated at Alphabet Inc., becoming an independent entity in 2022. Our mission is to develop commercial products for financial services, healthcare, telecommunications, public sector, and other computationally-intensive industries. Our team's unique approach enables cross-pollination across a diverse range of fields, from physics, computer science, neuroscience, mathematics, cryptography, natural sciences, and more! Our success comes from coalescing diverse talent to create an environment where experimental thinking and collaboration yield breakthrough physics + AI solutions. Join a culture where thought leadership, diverse talent, employee engagement, and technological impact will create the next tech uproar. We are deeply committed to education as a means to advance quantum solutions and computing initiatives. We invest in future talent through internship programs, research papers, developer tools, textbooks, educational talks/events, and partnerships with universities/talent hubs to attract multi-disciplinary talent. Our hope is to inspire people from all walks of life to be prepared for the quantum era and encourage a path in STEM.

ScieGen Pharmaceuticals Inc. is a fast growing generic pharmaceutical manufacturer located in Hauppauge, NY.

Scientific Industries, Inc, manufactures ALL the "GENIE" products in the USA. Equipment such as the well known VORTEX-GENIE, and other GENIE products used primarily for sample preparation and sample processing in the lab oratory market.r website www.scientificindustries.com to learn or find solutions to mixing, shaking, incubation for many types of samples.

The Integrated Genomics Operation (IGO) at Memorial Sloan Kettering (MSK) is a collaborative core facility dedicated to generating high-quality genomics data for basic, translational, and clinical research projects. The core is focused on Illumina Next-Generation Sequencing (NGS) while also providing comprehensive genomics services including pathological review of tissue samples, fragment analysis, Sanger sequencing, and much more.

SmartZyme is a life science company using PROVOLUTION™ , a proprietary technological platform for protein design and engineering, in accordance with industry required specifications. The company was founded in November 2013 by Shilo Ben Zeev (CEO) and David Baram, Ph.D. (CTO). The company aims to efficiently design and create proteins and potent enzymes with the specific characteristics required for optimal performance. Its products will be used to revolutionize industries by addressing unmet needs of various industrial fields. The company’s PROVOLUTION™ technology combines some of the most advanced scientific tools for protein engineering, computational biology and electrochemistry. These tools enable the development of improved, or “superior”, proteins and enzymes for wide ranging applications. The Company is currently focusing on the Diabetes market where it intends to launch its first two products: a pre-designed enzyme with superior characteristics for improved bio-electrochemical glucose catalysis, to be used on glucose test strips for the Self Monitoring Blood Glucose (SMBG) market. Strip manufacturers incorporating this superior enzyme in their products will be able to offer results which are far more accurate than current standard strips and ensure that their strips meet the rigid ISO 15197:2013 requirements. The company’s second product, the Go Patch Go™, personalized patient care system (PCS), an on-demand blood glucose measurement system in which measurement accuracy, enzyme stability and product shelf life are significantly enhanced due to the use of SmartZyme’s protein engineering technology. This product will offer diabetic patients a solution to current blood glucose monitoring systems which lack the optimal accuracy and stability required for effective treatment for diabetes. SmartZyme’s R&D efforts are supported by a scientific advisory board of leaders in the fields of protein engineering, structural biology and electrochemistry.

SolveBio is a data analytics company that specializes in advanced precision medicine for biopharma customers, aiming to lower trial risk, develop more effective therapeutics, and accelerate clinical development timelines.

Stony Brook Medicine expresses our shared mission of research, clinical care and education – a mission embraced by our faculty, staff, researchers, and students. It is the embodiment of everything we do on behalf of the health of patients – not only here in our community, but also in the region and worldwide. Stony Brook Medicine comprises five Health Sciences schools — Renaissance School of Medicine, School of Dental Medicine, School of Health Technology and Management, School of Nursing and School of Social Welfare — as well as Stony Brook University Hospital, Stony Brook Southampton Hospital, Stony Brook Eastern Long Island Hospital, Stony Brook Children’s Hospital and more than 200 community-based healthcare settings throughout Suffolk County. Our health sciences schools work in tandem with our research and clinical care teams to deliver the best ideas in medicine to patients. As an academic medical center, we are all about ideas. Creating them. Nurturing them. Protecting them. Challenging them. Improving them. Teaching them to others. And most importantly of all, delivering them to patients and their families – sooner, smarter and better. An “idea” can be a new treatment protocol, best practices, a bright new researcher we’ve brought in from another institution, the convenience of an outpatient clinic, or simply a more user-friendly way to access our medical care. Ideas drive us, they thrive here, and we are committed to bringing more of them to our patients than anyone else.

Sunrise Medical Laboratories. We put people first. For over 40 years, we at Sunrise Medical Laboratories have consistently provided our member physicians and their patients with the most accurate and diagnostically meaningful results possible. Our success stems from our commitment to three essential principles. Courtesy Whether you're a physician or a patient, your needs are our top priority. We are committed to providing prompt service, timely notice of appointments and results, and empowering our employees with the answers to any questions you may have. Compassion We know that medical testing can sometimes be worrisome or stressful. For this reason, we train our staff to provide information, care and comfort whenever needed. Whether it's distracting a child during a blood draw or explaining a complex test, we're glad to go the extra mile for each and every patient. Professional Expertise We continually invest in the most advanced technologies so that we can provide the highest quality medical laboratory services available. We are fully licensed and accredited by The College of American Pathologists (CAP), New York State Department of Health, the Center for Medicare and Medicaid Services (CLIA), U.S. Department of Health and Human Services (Medicare), and the Pennsylvania Department of Health. Because your well-being, comfort and peace-of-mind are utmost to our success, we are proud to say, "We take it personally".

The newly announced merger of NY-headquartered Symbio LLC and CA-headquartered Dow Development Laboratories LLC with Munster (Germany)-based Proinnovera will form Symbio Proinnovera, creating one of the world's largest specialized dermatology-focused clinical research organizations. Founded over 20 years ago, the Symbio & Dow Group has a full-service clinical trial CRO offering for dermatology, complemented by a business active in the pre-clinical formulation of topicals, providing its client's dermatology and aesthetics services - from pre-clinical formulation work to subsequent clinical trial execution. Proinnovera was founded 25 years ago and is a leading European CRO in the dermatology clinical trial space. It is a full-service CRO conducting clinical studies from Phase I to IV, as well as non-interventional and medical device studies. Proinnovera turns study data into oversight for clients to accelerate decision-making, increasing transparency and efficiency in the conduct of clinical trials. Both companies are proven market leaders among specialty dermatology CROs with exceptional geographical coverage. Their combined strength will enable them to excel at addressing customers' needs and expectations in all areas of research. The newly formed organization will leverage the combined power of two highly experienced teams with deep expertise in the dermatology space to generate efficiencies and accelerate clinical research. Symbio Proinnovera will be supported in its growth by ARCHIMED, a leading investment firm focused exclusively on healthcare industries.

The eye is the window into the body. Identifeye Health is creating a non-invasive test that detects health conditions through the eyes. Identifeye Health is part of the 4Catalyzer accelerator, with over $700 Million in funding, 300 scientists and engineers. Our offices are in Guilford CT, New York City, and Palo Alto. 4Catalyzer is founded by Jonathan Rothberg, the inventor of "Next-Gen" DNA sequencing and ultrasound-on-a-chip (Butterfly Network).

𝗧𝗛𝗘 𝗡𝗘𝗫𝗧 𝗚𝗘𝗡𝗘𝗥𝗔𝗧𝗜𝗢𝗡 𝗢𝗙 𝗘𝗚𝗚 𝗔𝗡𝗗 𝗘𝗠𝗕𝗥𝗬𝗢 𝗦𝗧𝗢𝗥𝗔𝗚𝗘 TMRW Life Sciences is a fertility technology company that provides safety and transparency to modernize and transform egg and embryo storage.   The current system is manual, outdated, and stressful for embryologists and clinicians. Automatization and state-of-the-art technology identify, track and remotely monitor frozen eggs and embryos. TMRW is a scalable solution for overcrowded clinics that have unintentionally become storage facilities since the rise in people seeking fertility treatments. Named Fast Company's #1 Most Innovative Biotech Company in 2022, TMRW is in leading clinics across the US and will soon be available in the UK and Europe.

Triad Isotopes is a manufacturer and supplier of radiopharmaceutical products.

TULA is the leading probiotic skincare and wellness brand, offering innovative products powered by probiotics extracts and superfoods that are both clean & clinically effective. As a digitally native and social first brand, we engage our customers at every touchpoint to help them feel confident in their skin and make it easier to achieve a healthy balance, inside and out. Alongside TULA.com we retail in North America with ULTA Beauty, Sephora, Nordstrom, and Amazon as well as internationally with Mecca in AUS & NZ, SpaceNK in the UK, and TMall in China. We raised a Series A led by L Catterton, the largest consumer-focused private equity group in the world, and now operate independently within Procter & Gamble's Specialty Beauty division. Our team has experience in some of the top consumer startups and beauty companies, and our team is fully remote.

Vader Environmental Nanotech is using biotechnology to fight chemical contamination such as PFAS and remove these contaminants from the environment. They have developed a high throughput screening technology to identify microbes that can use harmful chemicals as a food source.

Headquartered in Rochester, NY, VisualDx’s team of physicians, educators, and computer scientists have developed an award-winning web-based clinical decision support system to enhance clinical decision-making and improve patient care. It has become the tool of choice for front line health care workers who are looking for a visual, curated, peer-reviewed approach to medicine.

Werewool is a biomaterials company that develops fibers with tailored aesthetic and performance properties. The company designs fibers at the DNA level to create sustainable textiles with inherent properties.

With over 50 years of experience in generic pharmaceuticals, we provide superior customer care and stay true to our core values, creating opportunities for our customers, our markets, our products and our people. We provide affordable, necessary generic pharmaceuticals to enhance the lives of patients among many therapeutic categories.

ZeptoMetrix, an antylia scientific company, brings together some of the world's leading scientists in the fight against infectious disease. We are proud to offer an extensive range of research products and services that are continuously expanding. Our Mission "Partner to our Customer" is the basis for our successful collaboration with scientists across the globe.